Bc. Ruby et al., EFFECTS OF ESTRADIOL ON SUBSTRATE TURNOVER DURING EXERCISE IN AMENORRHEIC FEMALES, Medicine and science in sports and exercise, 29(9), 1997, pp. 1160-1169
The purpose of this investigation was to determine the effects of tran
sdermal estradiol (E2) replacement on substrate utilization during exe
rcise. Amenorrheic females (N = 6) performed three exercise trials fol
lowing 72 h of placebo (C 72) and 72 and 144 h of medicated transderma
l estradiol (E2) treatment (E2 72 and E2 144). Exercise involved 90 mi
n of treadmill running at 65% VO2max followed by timed exercise to exh
austion at 85% VO2max. Resting blood samples were obtained for glucose
, insulin, free fatty acids (FFA), and E2. Exercise blood samples were
obtained for E2, lactate, epinephrine, and norepinephrine. Rates of a
ppearance and disposal were calculated for glucose and glycerol using
a primed, continuous infusion of [6,6-H-2] glucose and [H-2(5)] glycer
ol. Medicated transdermal placement increased E2 significantly at rest
, before exercise (35.03 +/- 12.3, 69.5 +/- 20.1, and 73.1 +/- 31.6 pg
.mL(-1) for the C 72, E2 72, and E2 144 trials, respectively, P < 0.05
). Resting FFA increased significantly following E2 treatment (0.28 +/
- 0.16, 0.41 +/- 0.27, and 0.40 +/- 0.21 mmol.L-1 for the C 72, E2 72
and E2 144 trials, respectively, P < 0.05). Glucose Ra was significant
ly decreased during exercise as a result of E2 replacement (21.9 +/- 7
.7, 18.9 +/- 6.2, and 18.9 +/- 5.6 mu mol.kg(-1).min(-1) for the C 72,
E2 72, and E2 144 trials, respectively, P < 0.05). Average glucose Rd
also decreased during exercise as a result of E2 replacement (21.3 +/
- 7.8, 18.5 +/- 6.4, and 18.6 +/- 5.8 mu mol.kg(-1).min(-1) for the C
72, E2 72, and E2 144 trials, respectively, P < 0.05). However, the es
timated relative contribution of plasma glucose and muscle glycogen to
total carbohydrate oxidation was similar among the trials. Epinephrin
e values were significantly lower late in exercise during the E2 72 an
d E2 144 trials, compared with the C 72 trial (P < 0.05). These result
s indicate that elevated E2, levels can alter glucose metabolism at re
st and during moderate intensity exercise as a result of decreased glu
coneogenesis, epinephrine secretion, and/or glucose transport.